Matthias Dr. Müller-Gliemann

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Matthias Dr. Müller-Gliemann is active.

Explore More

Publication

Featured researches published by Matthias Dr. Müller-Gliemann.

Archive | 1997

Cycloalkano-pyridine as CETP inhibitors

Rolf Angerbauer; Hilmar Bischoff; Arndt Brandes; Klaus-Dieter Bremm; Michael Conrad; Henry Giera; Michael Lögers; Matthias Dr. Müller-Gliemann; Paul Naab; Holger Paulsen; Carsten Schmeck; Delf Schmidt; Gunter Schmidt; Joachim Schuhmacher; Jurgen Stoltefuss

Archive | 1997

Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents

Gunter Schmidt; Rolf Angerbauer; Arndt Brandes; Matthias Dr. Müller-Gliemann; Hilmar Bischoff; Delf Schmidt; Stefan Wohlfeil; William R. Schoen; Gaetan Ladouceur; James H. Cook; Timothy G. Lease; Donald John Wolanin; Richard H. Kramss; Donald L. Hertzog; Martin Osterhout

Archive | 1997

Heterocyclic condensed pyridines as CETP inhibitors

Rolf Angerbauer; Hilmar Bischoff; Arndt Brandes; Klaus-Dieter Bremm; Michael Lögers; Matthias Dr. Müller-Gliemann; Carsten Schmeck; Delf Schmidt; Gunther Schmidt; Joachim Schuhmacher

Archive | 1997

2-Aryl substituted pyridines

Gunter Schmidt; Rolf Angerbauer; Arndt Brandes; Michael Lögers; Matthias Dr. Müller-Gliemann; Hilmar Bischoff; Delf Schmidt; Stefan Wohlfeil

Archive | 1997

Heterocyclic-fused pyridines

Carsten Schmeck; Matthias Dr. Müller-Gliemann; Gunter Schmidt; Arndt Brandes; Rolf Angerbauer; Michael Lögers; Klaus-Dieter Bremm; Hilmar Bischoff; Delf Schmidt; Joachim Schuhmacher

Archive | 1992

Substituted biphenylpyridinones as angiotensin II antagonists

Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Johannes-Peter Stasch; Andreas Dr. Knorr; Stefan Wohlfeil; Walter Dr. Hübsch; Jürgen Dr. Dressel; Peter Fey; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Siegfried Zaiss

Archive | 1998

5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors

Matthias Dr. Müller-Gliemann; Rolf Angerbauer; Arndt Brandes; Michael Lögers; Carsten Schmeck; Gunter Schmidt; Klaus-Dieter Bremm; Hilmar Bischoff; Delf Schmidt

Archive | 1992

Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application

Ulrich Dr. Müller; Klaus Mohrs; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Walter Dr. Hübsch; Michael Matzke; Ulrich Niewohner; Siegfried Raddatz; Thomas Dr. Krämer; Matthias Dr. Müller-Gliemann; Hans-Peter Dr. Bellemann; Martin Dr. Beuck; Stanislav Kazda; Stefan Wohlfeil

Archive | 1993

Sulphonylbenzyl-substituted pyridones which are angiotension II receptor antagonists

Rudolf Dr. Hanko; Walter Dr. Hübsch; Jürgen Dr. Dressel; Peter Fey; Thomas Dr. Krämer; Ulrich Dr. Müller; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Claudia Hirth-Dietrich; Andreas Knorr; Johannes-Peter Stasch; Stefan Wohlfeil; Özkan Dr. Yalkinoglu

Archive | 1994

Substituted mono- and bipyridylmethylpyridones

Peter Fey; Walter Dr. Hübsch; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Hilmar Bischoff; Stefan Wohlfeil; Dirk Denzer; Stanislav Kazda; Johannes-Peter Stasch; Andreas Knorr; Siegfried Zaiss

Explore More